Oppenheimer analyst Hartaj Singh maintained a Buy rating on Moderna (NASDAQ:MRNA) on Sunday, setting a price target of 178,... By Rajesh Kumar Singh and Carl O'Donnell (Reuters) - An advisory ...

Her great-grandnephew's plan to put it in a temple for "spiritual seekers" would exclude her from art history all over again.

Financial giants have made a conspicuous bullish move on Moderna. Our analysis of options history for Moderna (NASDAQ:MRNA) revealed 17 unusual trades. Delving into the details, we found 47% of ...

In terms of liquidity and interest, the mean open interest for Moderna options trades today is 3103.07 with a total volume of 1,821.00. In the following chart, we are able to follow the development of ...

Barclays 27th Annual Global Healthcare Conference March 11, 2025 1:30 PM ETCompany ParticipantsRose Loughlin - EVP of ...

Walgreens jumps as Sycamore agrees to $11.45 a share purchase Sycamore Partners agreed to acquire Walgreens Boots (WBA) in a ...

Leaving Copenhagen’s castle-like station, the train (5.3 hours, from 35 euros) traversed the five-mile bridge connecting ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

GSK has filed a pair of lawsuits against Moderna, claiming infringement of patents covering mRNA vaccines for COVID-19 and respiratory syncytial virus (RSV). According to court documents ...

The trial compared Moderna's MRNA-4157/V940 vaccine given alongside Merck & Co's cancer immunotherapy Keytruda (pembrolizumab) to Keytruda alone in patients with the skin cancer melanoma.

material-symbols Latest variable icon fonts and CSS for Material Symbols. @material-symbols/font-100 Latest variable icon fonts with weight 100 for Material Symbols. @material-symbols/font-200 Latest ...